MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Net Income (Quarterly) : -14.84M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.84M |
| March 31, 2026 | -10.86M |
| December 31, 2025 | 15.19M |
| September 30, 2025 | 16.75M |
| June 30, 2025 | 9.618M |
| March 31, 2025 | 7.023M |
| December 31, 2024 | 7.438M |
| September 30, 2024 | 7.878M |
| June 30, 2024 | 17.62M |
| March 31, 2024 | 9.061M |
| December 31, 2023 | 51.29M |
| September 30, 2023 | 8.842M |
| June 30, 2023 | 9.251M |
| March 31, 2023 | -1.942M |
| December 31, 2022 | -0.414M |
| September 30, 2022 | -8.426M |
| June 30, 2022 | -10.87M |
| March 31, 2022 | -10.49M |
| December 31, 2021 | 2.215M |
| September 30, 2021 | -2.339M |
| June 30, 2021 | -1.779M |
| March 31, 2021 | -8.382M |
| December 31, 2020 | -16.58M |
| September 30, 2020 | -19.42M |
| June 30, 2020 | -8.466M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.821M |
| December 31, 2019 | -7.476M |
| September 30, 2019 | 12.38M |
| June 30, 2019 | -17.21M |
| March 31, 2019 | -13.27M |
| December 31, 2018 | -36.22M |
| September 30, 2018 | -0.178M |
| June 30, 2018 | 1.804M |
| March 31, 2018 | 4.619M |
| December 31, 2017 | 34.87M |
| September 30, 2017 | 17.46M |
| June 30, 2017 | 8.069M |
| March 31, 2017 | 4.327M |
| December 31, 2016 | 5.481M |
| September 30, 2016 | 3.321M |
| June 30, 2016 | 1.975M |
| March 31, 2016 | 1.197M |
| December 31, 2015 | 13.38M |
| September 30, 2015 | 6.551M |
| June 30, 2015 | 5.43M |
| March 31, 2015 | 4.087M |
| December 31, 2014 | 3.832M |
| September 30, 2014 | 3.700M |
| June 30, 2014 | -0.3902M |
| March 31, 2014 | -0.9221M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| ABVC BioPharma, Inc. | -0.8105M |
| Enovis Corp. | -1.036M |
| Edwards Lifesciences Corp. | 241.40M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 64.36M |
| Total Expenses (Quarterly) | 79.20M |
| EPS Diluted (Quarterly) | -0.1004 |
| Enterprise Value | 512.35M |
| Gross Profit Margin (Quarterly) | 68.50% |
| Profit Margin (Quarterly) | -23.06% |
| Earnings Yield | 0.92% |
| Operating Earnings Yield | 1.37% |
| Normalized Earnings Yield | 0.9205 |